SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
idiopathic pulmonary fibrosis
Journals
5
1
Medicine
2
The European respiratory journal
3
international journal of clinical oncology
4
experimental and therapeutic medicine
5
polski merkuriusz lekarski : organ polskiego towarzystwa lekarskiego
Research Groups
0
No Research Group Connected
Bibliographies
33
1
Diagnostic challenges in interstitial lung diseases using the example of microscopic usual interstitial pneumonia image in a patient with the clinical hypothesis of idiopathic pulmonary fibrosis - a case report.
2
Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study.
3
Comparative effectiveness of 3 Traditional Chinese Medicine treatment methods for idiopathic pulmonary fibrosis: A systematic review and network meta-analysis protocol.
4
Demystifying fibrotic hypersensitivity pneumonitis diagnosis: it's all about shades of grey.
5
Genetic Variation in CCL18 Gene Influences CCL18 Expression and Correlates with Survival in Idiopathic Pulmonary Fibrosis—Part B
6
Detection of microRNA expression levels based on microarray analysis for classification of idiopathic pulmonary fibrosis.
7
anti-cytokine therapy in fibrosing alveolitis: where are we now?
8
mesenchymal stem cells for the treatment of idiopathic pulmonary fibrosis
9
interstitial lung diseases in saudi arabia: a single-center study
10
genetics in idiopathic pulmonary fibrosis pathogenesis, prognosis, and treatment
11
skewed lung ccr4 to ccr6 cd4+ t cell ratio in idiopathic pulmonary fibrosis is associated with pulmonary function
12
june 2014 phoenix pulmonary journal club: new therapies for ipf and ebus for sardoidosis
13
approach to acute exacerbation of idiopathic pulmonary fibrosis
14
Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscape.
15
Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis
16
Is probable usual interstitial pneumonia pattern synonymous with idiopathic pulmonary fibrosis?
17
Clinical features and prognosis of microscopic polyangiitis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis
18
Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: Risk factors and outcome
19
Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
20
Idiopathic Pulmonary FibrosisâClinical presentation, outcome and baseline prognostic factors in a Portuguese cohort
21
The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
22
Recent clinical trials in idiopathic pulmonary fibrosis and the BUILD-1 study
23
Dysregulated balance of lung macrophage populations in idiopathic pulmonary fibrosis revealed by single-cell RNA seq: an unstable "ménage-à-trois".
24
Prediction of progression in idiopathic pulmonary fibrosis using CT scans at baseline: A quantum particle swarm optimization - Random forest approach.
25
Recapitulating idiopathic pulmonary fibrosis related alveolar epithelial dysfunction in a human iPSC-derived air-liquid interface model.
26
Correction to: Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.
27
Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data
28
a dataset of 26 candidate gene and proinflammatory cytokine variants for association studies in idiopathic pulmonary fibrosis (ipf): frequency distribution in normal czech population
29
activation of oncogenic pathways in idiopathic pulmonary fibrosis
30
anca-negative idiopathic pulmonary fibrosis developed into anca-positive rapidly progressive glomerulonephritis after 12 years follow up
31
adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national survey
32
mmrc dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis
33
analysis of microarray-identified genes and micrornas associated with idiopathic pulmonary fibrosis